Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination
Cutaneous dysesthesia / allodynia emerging, dose-related, reversible
TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
It's been shown in a sprawling body of preclinical research to have profound regenerative effects, particularly in healing tendons, ligaments, muscles, and, perhaps most importantly for this topic, the gastrointestinal tract itself
BPC-157 has shown promise in treating numerous other conditions, and researchers are calling for additional studies to assess its efficacy in treating the following ones: Traumatic brain injury Parkinsons disease Ocular dysfunction Seizures Depression Anxiety Alcoholism and drug addiction Drug withdrawal Allergies Viruses How Quickly You Might Notice Results BPC-157 therapeutic results differ among people and depending on the condition being treated